-
Founded in:
1992-03-31 -
Country:
China -
Address:
No. 789, Xinluo Street, Jinan High-tech Development Zone -
Tax NO.:
913701006140705563 -
Registered Funds:
90 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Neostigmine Methyl Sulfate |
Directly affects the nerves that regulate farsightedness in the eye to improve eye fatigue
More
Directly affects the nerves that regulate farsightedness in the eye to improve eye fatigue |
0.01mg | 51-60-5 | 31 |
| Taurine |
Promote eye nutrition, accelerate cell metabolism, enhance eye resistance, thereby preventing eye diseases and promoting the repair of inflammatory damage
More
Promote eye nutrition, accelerate cell metabolism, enhance eye resistance, thereby preventing eye diseases and promoting the repair of inflammatory damage |
1mg | 107-35-7 | 17 |
| Vitamin B6 |
Promote eye nutrition, accelerate cell metabolism, enhance eye resistance, thereby preventing eye diseases and promoting the repair of inflammatory damage
More
Promote eye nutrition, accelerate cell metabolism, enhance eye resistance, thereby preventing eye diseases and promoting the repair of inflammatory damage |
1mg | 8059-24-3 | 13 |
| Chlorphenamine maleate |
Relieve or eliminate eye inflammation caused by allergies, especially itchy eyes
More
Relieve or eliminate eye inflammation caused by allergies, especially itchy eyes |
0.1mg | 113-92-8 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Levofloxacin hydrochloride |
It achieves antibacterial effect by inhibiting the activity of bacterial topoisomerase IV and DNA gyrase, hindering the replication of bacterial DNA. It has good antibacterial effect on most Enterobacteriaceae, some methicillin-sensitive Staphylococci, Streptococcus pneumoniae, Streptococcus pyogenes, hemolytic Streptococcus, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci.
More
It achieves antibacterial effect by inhibiting the activity of bacterial topoisomerase IV and DNA gyrase, hindering the replication of bacterial DNA. It has good antibacterial effect on most Enterobacteriaceae, some methicillin-sensitive Staphylococci, Streptococcus pneumoniae, Streptococcus pyogenes, hemolytic Streptococcus, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci. |
177325-13-2 | 18 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ofloxacin |
It works by inhibiting DNA gyrase and DNA replication in bacterial prokaryotes. Due to its unique mechanism of action, it has the characteristics of a broad antibacterial spectrum and strong antibacterial activity, and has a strong antibacterial effect on both Gram-positive and Gram-negative bacteria. It is effective against infections such as Staphylococcus, Streptococcus pyogenes, Streptococcus hemolyticus, Enterococcus, Pneumococcus, Escherichia coli, Citrobacter, Klebsiella pneumoniae, Enterobacter, Serratia, Proteus, Pseudomonas aeruginosa, Haemophilus influenzae, Acinetobacter, CamPylobacter, PeptostoreptoCoCus, and Chlamydia sensitive strains. There is no cross-resistance between this product and other antibacterial drugs.
More
It works by inhibiting DNA gyrase and DNA replication in bacterial prokaryotes. Due to its unique mechanism of action, it has the characteristics of a broad antibacterial spectrum and strong antibacterial activity, and has a strong antibacterial effect on both Gram-positive and Gram-negative bacteria. It is effective against infections such as Staphylococcus, Streptococcus pyogenes, Streptococcus hemolyticus, Enterococcus, Pneumococcus, Escherichia coli, Citrobacter, Klebsiella pneumoniae, Enterobacter, Serratia, Proteus, Pseudomonas aeruginosa, Haemophilus influenzae, Acinetobacter, CamPylobacter, PeptostoreptoCoCus, and Chlamydia sensitive strains. There is no cross-resistance between this product and other antibacterial drugs. |
82419-36-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| N-ethyl-N-(4-pyridylmethyl)-alpha;-(hydroxymethyl)-phenylacetamide |
This product is an anticholinergic drug that can block the excitation of the iris sphincter and ciliary muscle caused by acetylcholine. Its 0.5% solution can cause mydriasis; 1% solution can cause ciliary muscle paralysis and mydriasis.
More
This product is an anticholinergic drug that can block the excitation of the iris sphincter and ciliary muscle caused by acetylcholine. Its 0.5% solution can cause mydriasis; 1% solution can cause ciliary muscle paralysis and mydriasis. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Erythromycin |
Erythromycin is a macrolide antibiotic, which has antibacterial activity against Staphylococcus, various groups of Streptococcus and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide.
More
Erythromycin is a macrolide antibiotic, which has antibacterial activity against Staphylococcus, various groups of Streptococcus and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide. |
80,000unit | 114-07-8 | 43 |